Franklin Resources
DYN icon

Franklin Resources’s Dyne Therapeutics DYN Stock Holding History

Franklin Resources’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.1M Buy
2,030,819
+21,737
+1% +$404K 0.01% 710
2026
Q1 		$36.4M Buy
2,009,082
+2,444
+0.1% +$42.1K 0.01% 743
2025
Q4 		$39.2M Buy
2,006,638
+608,108
+43% +$11.5M 0.01% 717
2025
Q3 		$17.7M Buy
1,398,530
+8,390
+0.6% +$95.7K ﹤0.01% 986
2025
Q2 		$13.2M Sell
1,390,140
-24,695
-2% -$272K ﹤0.01% 1044
2025
Q1 		$14.8M Buy
1,414,835
+91,032
+7% +$1.3M ﹤0.01% 990
2024
Q4 		$31.2M Sell
1,323,803
-18,697
-1% -$553K 0.01% 772
2024
Q3 		$44.7M Sell
1,342,500
-371,996
-22% -$14.8M 0.01% 644
2024
Q2 		$60.5M Sell
1,714,496
-68,775
-4% -$2M 0.02% 507
2024
Q1 		$50.6M Sell
1,783,271
-130,561
-7% -$2.95M 0.02% 566
2023
Q4 		$25.5M Buy
1,913,832
+876
+0% +$8.56K 0.01% 695
2023
Q3 		$17.1M Sell
1,912,956
-523
-0% -$5.63K 0.01% 785
2023
Q2 		$21.5M Buy
1,913,479
+21,120
+1% +$249K 0.01% 742
2023
Q1 		$21.8M Buy
1,892,359
+114,058
+6% +$1.48M 0.01% 743
2022
Q4 		$20.6M Sell
1,778,301
-4,570
-0.3% -$52.9K 0.01% 765
2022
Q3 		$22.6M Buy
1,782,871
+36,390
+2% +$417K 0.01% 740
2022
Q2 		$12M Buy
1,746,481
+568,533
+48% +$3.92M 0.01% 906
2022
Q1 		$11.4M Sell
1,177,948
-14,450
-1% -$123K ﹤0.01% 980
2021
Q4 		$14.2M Buy
1,192,398
+70,785
+6% +$995K 0.01% 974
2021
Q3 		$18.2M Buy
1,121,613
+85,666
+8% +$1.52M 0.01% 914
2021
Q2 		$21.8M Buy
1,035,947
+104,742
+11% +$1.97M 0.01% 838
2021
Q1 		$14.5M Sell
931,205
-571,000
-38% -$11.1M 0.01% 903
2020
Q4 		$31.5M Sell
1,502,205
-245,352
-14% -$4.85M 0.01% 717
2020
Q3 		$35.3M Buy
+1,747,557
New +$38.4M 0.02% 644

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources's DYN Position: Q2 2026 in Review

Franklin Resources increased its Dyne Therapeutics (DYN) stake by 1.1% in Q2 2026, buying an estimated $404K and bringing the position to 2,030,819 shares worth $45.1M. The position accounts for 0.01% of the portfolio, ranked #710.

Franklin Resources first reported a position in DYN in Q3 2020 and has held it in 24 quarters since. The position peaked at $60.5M in Q2 2024. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Franklin Resources held 2,030,819 shares of Dyne Therapeutics worth $45.1M as of Q2 2026.
  • Franklin Resources bought 21,737 Dyne Therapeutics shares in Q2 2026, an estimated $404K.
  • Dyne Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #710 holding.
  • Franklin Resources first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Franklin Resources's Dyne Therapeutics position peaked at $60.5M in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.